BAT Releases glo HYPER PRO in Bosnia and Herzegovina

BAT by 2FIRSTS.ai
Jun.21.2024
BAT Releases glo HYPER PRO in Bosnia and Herzegovina
British American Tobacco (BAT) launched its latest heated tobacco device, glo HYPER PRO, in Bosnia and Herzegovina on June 20th.

According to a report by Bljesak.Info on June 20th, British American Tobacco (BAT) unveiled its latest heated tobacco device, glo HYPER PRO, for the first time in Bosnia and Herzegovina.

 

Previously, glo HYPER PRO had been launched in Croatia, Serbia, Italy, Poland, Japan, and other countries. With the launch of glo HYPER PRO, BAT became the first tobacco company to offer all categories of smokeless products (including e-cigarettes, nicotine pouches, and the current glo HYPER PRO heated tobacco product) in the Bosnian market. The company claims that these are also important steps towards BAT's commitment to creating "A Better Tomorrow™" and realizing its vision of a smoke-free world. The company's strategic goal is to shift smokers from traditional tobacco products to lower-risk alternative products, with the aim of becoming the leading company in the smokeless industry by 2035.

 

Furthermore, BAT emphasized its significant contribution to the economy of Bosnia and Herzegovina. BAT has operations in the country, including corporate offices and iNovina, as well as over 400 iNovina kiosks nationwide. In addition, they directly employ over 1000 people in Bosnia and Herzegovina, providing more job opportunities for locals. In 2023, they contributed 336 million convertible marks (KM) to the national budget of Bosnia and Herzegovina.

 

BAT Bosnia and Herzegovina director Johan Baguca stated that

 

The glo HYPER PRO is not just a device, but a perfect combination of technological innovation and exquisite design. Its aim is to introduce new technologies, such as smart LED screens and the HeatBoost induction heating system... For us, the most important thing is the satisfaction of nearly nine million adult glo users worldwide. We believe that this device will be well-received in Bosnia and Herzegovina and will certainly further enhance our position as the only company in the industry to offer a full range of low-risk smoke-free products in the country.

 

The General Manager of BAT Adriatic Region, Zvonko Kolobara, stated

 

I am proud of the launch of our glo HYPER PRO device, which has fully encompassed the low risk product category in the entire Adriatic region market, including Bosnia and Herzegovina, within our BAT product line. This is crucial for BAT and our future business. The key is that we need to offer as wide a range as possible of lower risk alternative products for our consumers, adult smokers. Over the past three years, BAT has invested over 1.4 billion euros in research and development, commercialization, and scientific studies to support its portfolio of lower risk tobacco and nicotine products. These efforts are crucial, as clear regulatory frameworks are needed to differentiate between tobacco and lower risk products and understand the potential of these alternatives for adult smokers.

 

Currently, the glo HYPER PRO device is now available for purchase at iNovina newsstands and other retail locations in Bosnia and Herzegovina.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Russia has placed shares in four Japan Tobacco International businesses under temporary management, the first such move involving a major global tobacco manufacturer, according to Interfax. JTI held 35.8% of Russia's tobacco market by volume in the first nine months of 2026. While British American Tobacco and Imperial Brands have exited Russia, Philip Morris International continues operating there. As the market changes and diplomatic efforts continue, could international tobacco companies that left Russia eventually return?
Nov.06
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Philip Morris Japan (PMJ) launched the limited-edition IQOS ILUMA i PRIME Soundsorial Model in collaboration with French audio brand DEVIALET on October 1, 2026. Featuring sound-wave patterns, a silver-and-black finish and a gradient holder, the heated tobacco device is priced at JPY 15,980, including tax, and is available at four IQOS stores in Japan. According to Japanese media citing a PMJ representative, about 1,900 units were allocated to the Japanese retail market. A separate Soundsorial Collection, combining the device with DEVIALET Gemini II earbuds, includes 440 sets allocated to Japan for a membership prize draw.
product
Oct.23
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Vaping prevalence in Great Britain edged down to 9.9% in 2025 from 10.0% in 2024, with the number of adult users holding at approximately 5.4 million for a second consecutive year, according to the Office for National Statistics (ONS). E-cigarette use had risen from 6.4% in 2020 to 10.0% in 2024, when it exceeded cigarette smoking prevalence for the first time. Cigarette smoking continued to decline to 8.7% in 2025, widening the gap to 1.2 percentage points. Daily vaping declined slightly, while usage among adults aged 25–34 increased despite falling rates in other age groups.
DATA
Oct.14
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26